Your browser doesn't support javascript.
loading
Fluvoxamine for the treatment of COVID-19.
Nyirenda, John Lz; Sofroniou, Mario; Toews, Ingrid; Mikolajewska, Agata; Lehane, Cornelius; Monsef, Ina; Abu-Taha, Aesha; Maun, Andy; Stegemann, Miriam; Schmucker, Christine.
Afiliación
  • Nyirenda JL; Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Sofroniou M; Public Health Department, Faculty of Applied Sciences, University of Livingstonia, Mzuzu, Malawi.
  • Toews I; Institute of General Practice/Family Medicine, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Mikolajewska A; NHS South West England, National Health Service, England, UK.
  • Lehane C; Fellow, Royal College of General Practitioners, FRCGP, London, UK.
  • Monsef I; Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Abu-Taha A; Centre for Biological Threats and Special Pathogens (ZBS), Strategy and Incident Response (ZBS7), Clinical Management and Infection Control (ZBS7.1), Robert Koch Institute, Berlin, Germany.
  • Maun A; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Stegemann M; Department of Anesthesiology, University Heart Center Freiburg, Bad Krozingen, Freiburg, Germany.
  • Schmucker C; Faculty of Medicine and University Hospital Cologne, University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cochrane Haematology, Cologne, Germany.
Cochrane Database Syst Rev ; 9: CD015391, 2022 09 14.
Article en En | MEDLINE | ID: mdl-36103313

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_covid_19 Asunto principal: Deterioro Clínico / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Cochrane Database Syst Rev Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_covid_19 Asunto principal: Deterioro Clínico / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Cochrane Database Syst Rev Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Alemania
...